Clinical and biochemical outcome of conventional dose radiotherapy for localized prostate cancer
Charles Catton1, Mary Gospodarowicz1, Jimmy Mui1, Tony Panzarella2, Michael Milosevic1, Michael McLean1, Pamela Catton1, Padraig Warde1
Canadian Journal of Urology, Vol.9, No.1, pp. 1444-1452, 2002
Abstract Purpose: To retrospectively review the results of conventional dose radical radiotherapy for clinical stage T1 and T2 prostate cancer, and to identify the factors that predict the biochemical relapse-free rate.
Methods: The records were reviewed of 706 hormonally-naive men with clinical stage T1T2 prostate cancer treated with radical radiotherapy (RT) between 1987-1994 at the Princess Margaret Hospital. The median prostate RT dose was 65 Gy in 35 fractions (range 52 Gy in 20 fractions to 67 Gy in 37 fractions). Pelvic lymph nodes were included in the treatment volume and treated to a median dose of 45… More >